As of 2026-05-12, the Intrinsic Value of Preveceutical Medical Inc (PREV.CN) is -0.07 CAD. This PREV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Preveceutical Medical Inc is -446.12%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Preveceutical Medical Inc (PREV.CN) is overvalued by 446.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.07 - -0.07 | -0.07 | -446.12% |
| DDM - Stable | (0.04) - (0.13) | (0.09) | -535.4% |
| DDM - Multi | (0.02) - (0.05) | (0.03) | -235.1% |
| Market Cap (mil) | 11.96 |
| Beta | -1.71 |
| Outstanding shares (mil) | 598.19 |
| Enterprise Value (mil) | 16.46 |
| Market risk premium | 5.10% |
| Cost of Equity | 10.02% |
| Cost of Debt | 5.00% |
| WACC | 8.65% |